Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 3,713,496 |
|
|||||
| News | (1) | ||||||
| Day High | 1.42 | Low High |
|||||
| Day Low | 1.26 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Veru Inc | VERU | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.12 | 9.60% | 1.37 | 18:56:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.26 | 1.26 | 1.42 | 1.35 | 1.25 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 13,395 | 3,713,496 | US$ 1.36 | US$ 5,049,164 | - | 0.36 - 1.92 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:54:02 | 1 | US$ 1.37 | USD |
Veru Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 199.08M | 146.38M | - | 16.3M | -93.09M | -0.64 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Veru News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VERU Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.29 | 1.48 | 1.17 | 1.26 | 1,966,318 | 0.08 | 6.20% |
| 1 Month | 0.7204 | 1.92 | 0.6999 | 1.38 | 3,856,592 | 0.6496 | 90.17% |
| 3 Months | 0.4849 | 1.92 | 0.3612 | 0.9902325 | 2,520,449 | 0.8851 | 182.53% |
| 6 Months | 0.90 | 1.92 | 0.36 | 0.8625987 | 1,963,826 | 0.47 | 52.22% |
| 1 Year | 1.28 | 1.92 | 0.36 | 0.948363 | 1,592,680 | 0.09 | 7.03% |
| 3 Years | 9.105 | 24.55 | 0.36 | 10.39 | 4,401,986 | -7.74 | -84.95% |
| 5 Years | 1.34 | 24.56 | 0.36 | 10.22 | 3,244,666 | 0.03 | 2.24% |
Veru Description
| Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States. |
